spacer
home > epc > summer 2002 > change management through the looking glass
PUBLICATIONS
European Pharmaceutical Contractor

Change Management Through the Looking Glass

Beyond the world of comfortable consistency lies a wonderland of chaotic uncertainty - the domain of change. The journey down the rabbit hole to the unknown often begins as a peek into tiny management and process doorways through which we want to squeeze painlessly into a beautiful garden of transformation. Change is never easy. Lewis Carroll's Alice in Wonderland began navigating change by questioning her very name and then swimming in a pool of her own tears. Dealing with change is no less demanding in the pharmaceutical industry. Competitive stakes are high and getting higher. The first company to market with a blockbuster drug can enjoy a virtual monopoly for years and possibly transform the lives of millions of people. Accepting the inevitability of change is a start. However, it is those who harness and manage the power of change that can sustain the momentum of competitive advantage.

Change and adaptation within the clinical trial process - particularly through effective automation - can make a tremendous difference to business throughput. Over time, the clinical trial process has evolved into an administrative hierarchy. People with years of experience in this context implement various common methodologies accepted for their apparent reliability. But the pressure of competition has no respect for hierarchy. Commonly accepted practices are rarely an adequate basis for breakthrough competitive results. Many of the delays in the drug development process are largely a consequence of slow adaptation to the pressures of competitive change.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Philip Holt, Vice President of Life Sciences at Integic Corporation

Philip Holt is Vice President of Life Sciences at Integic Corporation. He has worked extensively over the past two decades in the development of technology strategies and methodologies oriented toward repeatable results.

Philip has also held management and executive positions at Baxter, Oacis Healthcare Systems and SAIC, as well as founding Altis, an international consultancy.

spacer
Philip Holt
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

AirBridgeCargo expands its passive pharma solutions in partnership with SkyCell as it achieves the two-fold volume increase

AirBridgeCargo expands its passive pharma solutions in partnership with SkyCell as it achieves the two-fold volume increase AirBridgeCargo Airlines (ABC), one of the leaders in transportation of pharmaceutical products by air, and Zurich-based cold-chain ULD manufacturer SkyCell have sealed their partnership for the lease of all types of SkyCell containers to meet the demand for evolving volumes of passive pharmaceutical shipments, which reached around 3,500 tonnes for 1Q 2019 YOY and demonstrated a two-fold increase.
More info >>

White Papers

Overcoming research challenges with Adaptive Trials

PCI Pharma Services

There has been cause for concern within the pharmaceutical industry over the last five years, regarding increasing research and development costs, combined with a fall in the number of new drugs brought to market. In an attempt to overcome this issue there has been a significant rise in the use of adaptive clinical trial designs, whilst saving time and money as well as facilitating more effective decision making. One of the biggest challenges that pharmaceutical companies have experienced has been delivering compliant clinical trials supplies across diverse patient populations in the relatively short timeframes that adaptive trial designs require, remaining focused on ensuring that patient compliance and product quality is in no way compromised. This demand has led to the launch of fast response services that support Research and Development in responding to changing dosing regimens mid-trial.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement